CClinicalTrials.gg
Sign In
Not yet recruitingNCT06535438Updated Aug 2, 2024

The Role of Noncontrast Computed Tomography Markers in Predicting the Clinical Outcome of Cerebral Hemorrhage

An observational study in Intracerebral Hemorrhage, sponsored by Jin Hu. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-08-02.

Sponsored by Jin Hu · Observational

From the registry’s dates

  • Primary completion was expected by Aug 2024, 2 years 1 month ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
1,000
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this observational study is to To investigate the ability of Noncontrast Computed Tomography to predict clinical prognosis in Intracerebral Hemorrhage.

The main question it aims to answer is:How to judge the prognosis of patients with cerebral hemorrhage by CT image reading at admission.

02

Conditions studied

  • Intracerebral Hemorrhage

Keywords

  • ICH
03

In context

Cerebral Hemorrhage

476 studies on the registry are indexed under Cerebral Hemorrhage; 181 are open to participants now.

This study's planned enrollment of 1,000 is above the median of 275 across 180 observational studies indexed under Cerebral Hemorrhage.

Browse Cerebral Hemorrhage studies →

Lead sponsor

Jin Hu is the lead sponsor of 2 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with cerebral hemorrhage who met the criteria and were admitted continuously within the time period

Inclusion criteria

  1. Age≥18 years
  2. had completed a CT examination within 24 h of disease onset;
  3. had a hemorrhage that was located in the brain parenchyma, including the basal ganglia, thalamus,brain lobes, brainstem, and cerebellum.

Exclusion criteria

Exclusion Criteria:

  1. had secondary ICH caused by brain trauma,cerebrovascular malformations, aneurysms, and tumors;
  2. had ischemic cerebral infarction hemorrhagic transformation;
  3. had undergone surgical treatment (e.g.hematoma removal or puncture drainage) before the CT examination;
  4. had images of poor quality that could notbe accurately evaluated;
  5. had a hematoma withborders that could not be delineated, thus precluding delineation of the region of interest (ROI).
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
1,000 participants (estimated)
Patient registry
No

Groups and cohorts

  • The prognosis of cerebral hemorrhage is good at 90 days
  • The prognosis of cerebral hemorrhage is poor at 90 days
06

What researchers measure

Primary outcomes

  1. The prognosis of cerebral hemorrhage at 90 days

    The Modified Rankin Scale was used to evaluate the prognosis of the patients, and MRS Score \>2 indicated poor prognosis

    Time frame: 90 days

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 2, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06535438
Lead sponsor
Jin Hu
Responsible party
Jin Hu (Huashan Hospital, Fudan University, Huashan Hospital) — Sponsor-investigator
First posted
Aug 2, 2024
Start date
Aug 1, 2024 (estimated)
Primary completion
Aug 31, 2024 (estimated)
Completion
Aug 31, 2024 (estimated)
Last update
Aug 2, 2024

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Cerebral Hemorrhage→

Other studies from this sponsor

Jin Hu

Start the discussion